Modeling and simulation’s positive impact on NDA and BLA approvals through July 1, 2018 has included first use, orphan and priority review drugs for multiple indications PRINCETON, NJ – Certara®, the global leader in model-informed drug development, regulatory science, market access and real-world evidence services, today reported that 95% of novel new drug approvals by the […]
Covaris and Bioz Have Partnered to Bring Data and Transparency to the Customer Experience LOS ALTOS, CA – Bioz, Inc., a Silicon Valley AI data company, is proud to announce a new partnership with Covaris, Inc., the gold standard of DNA fragmentation in Next Generation Sequencing. By combining the latest advances in Natural Language Processing […]
Biomedical research faces enormous challenges as the volume of genomic, transcriptomic, metabolomic, phenotypic, and other data generated in research labs across the world continues to grow. According to the National Center for Biotechnology Information, the total amount of sequence data alone is doubling every seven months. Although analyzing this staggering amount of data presents the potential […]
Streamlines genome interpretation to improve the utility of genomic data Illumina, Inc. announces the release of open source, novel artificial intelligence (AI) software that can distinguish between potential disease-causing mutations, and the millions of benign genetic variants in individuals. The new AI software for genome interpretation has been publicly released through Illumina’s BaseSpace Sequence Hub and GitHub. […]
Researchers to access list of novel targets for Alzheimer’s disease treatment SEATTLE–Sage Bionetworks announces the launch of the Agora platform (agora.ampadportal.org) an interactive, web-based tool that allows researchers to explore curated genomic analyses of Alzheimer’s Disease (AD), including a list of early candidate target nominations for AD. The analyses accessible through Agora represent the culmination of over […]
Simulations Plus, Inc. (Nasdaq: SLP), the leading provider of modeling and simulation solutions for the pharmaceutical, biotechnology, chemicals, and consumer goods industries, today announced that it has entered into a one-year funded research collaboration with a large European consortium to further develop and validate the mechanistic Transdermal Compartmental Absorption and Transit (TCAT™) model in GastroPlus™. Dr. […]
London – Lifebit, the startup building a fully-automated system that generates and processes genomics data in real time at scale, today announces that it has closed a $3m (£2.25m) Seed funding round led by Pentech and Connect Ventures, with participation from Beacon Capital and Tiny VC (AngelList). The company is simultaneously announcing the launch of […]
Combining the world-leading proteomic and artificial intelligence/machine learning technologies to produce novel, actionable health insights across many diseases, conditions and markets SomaLogic and GNS Healthcare announced today that SomaLogic has obtained a license to apply GNS Healthcare’s proprietary REFS™ (Reverse Engineering & Forward Simulation) causal machine learning technology to SomaLogic’s proprietary SOMAscan®-derived protein data sets. […]
Sequences and Assay Data Captured in a Single Platform CDD Vault recently updated the text readout size (now 65,000 characters) for both the Synonyms and Protocol Readouts to lay the groundwork for assisting researchers using biologics instead of traditional small molecules. CDD Vault has a powerful storage and query engine to store and mine your […]
Consortium chooses Genedata Selector as bioinformatics solution for production of industrial polyketides. Munich, Germany Genedata, a leading provider of advanced software solutions for R&D, today announced that the MyBio consortium has chosen Genedata Selector® as its genome management and characterization platform to support its highly innovative R&D work in antibiotics. MyBio is an interdisciplinary consortia […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
